A series of biomarker discoveries developed by Robert B. Jenkins M.D.,Ph.D.,George Klee,M.D.,Ph.D.,George Vasmatzis,Ph.D.,and their colleagues at Mayo Clinic,along with Donald Connelly,M.D.,Ph.D.,of the University of Minnesota,have resulted in a licensed technology that will benefit prostate cancer patients globally. Mayo Clinic Research News and Discovery’s [...]











































